219 related articles for article (PubMed ID: 31777190)
21. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang Z; Chen P; Xie H; Cao P
Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
[TBL] [Abstract][Full Text] [Related]
22. Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis.
Niu Y; Huang T; Lian F; Li F
Tumour Biol; 2013 Dec; 34(6):3667-74. PubMed ID: 23807679
[TBL] [Abstract][Full Text] [Related]
23. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.
Zhang J; Shao C; Zhou Q; Zhu Y; Zhu J; Tu C
Mol Clin Oncol; 2015 Sep; 3(5):1165-1171. PubMed ID: 26623071
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
Cui K; Ou Y; Shen Y; Li S; Sun Z
Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
[TBL] [Abstract][Full Text] [Related]
26. Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis.
Chang Y; Liu B; Niu H; Wang Z; Xia S; Li H
Medicine (Baltimore); 2020 Aug; 99(34):e21887. PubMed ID: 32846849
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of circulating microRNAs for hepatocellular carcinoma.
Yang Y; Zhu R
Mol Biol Rep; 2014 Oct; 41(10):6919-29. PubMed ID: 25030834
[TBL] [Abstract][Full Text] [Related]
28. Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.
Zhao ZH; Fan YC; Yang Y; Wang K
World J Gastroenterol; 2013 Nov; 19(41):7189-96. PubMed ID: 24222965
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs as biomarkers for hepatocellular carcinoma: a diagnostic meta-analysis.
Hu QY; Jiang H; Su J; Jia YQ
Clin Lab; 2013; 59(9-10):1113-20. PubMed ID: 24273935
[TBL] [Abstract][Full Text] [Related]
30. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
31. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Lin S; Hu S; Ran Y; Wu F
Transl Cancer Res; 2021 Apr; 10(4):1667-1678. PubMed ID: 35116492
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of magnetic resonance imaging features of microvascular invasion in hepatocellular carcinoma: a meta-analysis.
Wang L; Jia M; Wen X; Shen J; Yang H
Diagn Interv Radiol; 2022 Sep; 28(5):428-440. PubMed ID: 36218148
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data.
Zhang WT; Gil-Gómez A; Liu CH; Gao SS; Romero-Gómez M
Rev Esp Enferm Dig; 2022 May; 114(5):280-288. PubMed ID: 34423645
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis.
Fang P; Du L; Cai D
Medicine (Baltimore); 2020 Mar; 99(12):e19461. PubMed ID: 32195943
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic performance of des-γ-carboxy prothrombin (DCP) for hepatocellular carcinoma: a bivariate meta-analysis.
Gao P; Li M; Tian QB; Liu DW
Neoplasma; 2012; 59(2):150-9. PubMed ID: 22248272
[TBL] [Abstract][Full Text] [Related]
38. Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
Xiong J; Luo J; Bian J; Wu J
Eur Radiol; 2022 Feb; 32(2):1285-1296. PubMed ID: 34357448
[TBL] [Abstract][Full Text] [Related]
39. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
[TBL] [Abstract][Full Text] [Related]
40. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
Christou C; Stylianou A; Gkretsi V
Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
